Suppr超能文献

新冠病毒管理的伪科学和欺诈产品。

Pseudoscience and fraudulent products for COVID-19 management.

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, Navrangpura, Ahmedabad, 380009, Gujarat, India.

Department of Pharmaceutical Chemistry, Bharati Vidyapeeth's Poona College of Pharmacy, Pune, 411038, Maharashtra, India.

出版信息

Environ Sci Pollut Res Int. 2022 Sep;29(42):62887-62912. doi: 10.1007/s11356-022-21967-4. Epub 2022 Jul 14.

Abstract

As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunity against the newer strains of SARS-CoV-2. Due to such a dreadful situation, lots of fear and depression have been created among the public. People are looking for the treatment of the disease at any cost and there is a race in the market to provide treatment and make money, whether it is effective or not! In such a condition, many fraud products, remedies, and myths have come into the market, which is falsely claimed to be effective for the disease and can harm the patients. Hence, FDA has banned such products and remedies. In this review, we have compiled all such fraudulent and pseudosciences identified for COVID-19. Currently, in the pandemic time, health agencies are approving the repurposed medicines based on the small-scale clinical data for emergency uses that become ineffective (most of the cases) after large randomized clinical studies. Proper vigilance strategies need to be defined by the regulatory agencies of the nation and routine awareness programs shall be arranged for educating the people and healthcare workers on routine updates.

摘要

截至目前,COVID-19 疫情已失控,在全球范围内广泛传播。此外,一些国家发现了变异病毒的新变种,其危险性比原始毒株更高。即使是疫苗也无法对 SARS-CoV-2 的新型菌株产生完全的保护免疫。由于这种可怕的情况,公众中产生了大量的恐惧和沮丧。人们不惜一切代价寻找治疗疾病的方法,市场上也出现了竞相提供治疗方法和赚钱的局面,无论是否有效!在这种情况下,许多欺诈产品、疗法和神话已经进入市场,这些产品和疗法被虚假声称对该疾病有效,但实际上可能会伤害患者。因此,FDA 已经禁止了这些产品和疗法。在本次综述中,我们汇总了所有针对 COVID-19 的欺诈性和伪科学产品。目前,在大流行期间,卫生机构根据小型临床试验数据批准了重新用于紧急用途的药物,但这些药物在大规模随机临床试验后往往变得无效(大多数情况如此)。国家监管机构需要制定适当的警惕策略,并安排常规宣传计划,为民众和医护人员提供关于常规更新的教育。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8a2/9282830/023b3c9f8711/11356_2022_21967_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验